Waters Corporation (NYSE:WAT) Director Thomas P. Salice sold 3,500 shares of the firm’s stock in a transaction dated Monday, November 20th. The shares were sold at an average price of $200.03, for a total transaction of $700,105.00. Following the completion of the transaction, the director now directly owns 20,349 shares in the company, valued at approximately $4,070,410.47. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Shares of Waters Corporation (NYSE WAT) opened at $196.57 on Friday. The firm has a market cap of $15,633.81, a P/E ratio of 27.30, a P/E/G ratio of 2.85 and a beta of 0.83. The company has a debt-to-equity ratio of 0.66, a current ratio of 6.16 and a quick ratio of 5.71. Waters Corporation has a 52-week low of $133.35 and a 52-week high of $200.71.

Waters Corporation (NYSE:WAT) last announced its quarterly earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.03. The business had revenue of $565.58 million for the quarter, compared to the consensus estimate of $555.25 million. Waters Corporation had a net margin of 24.34% and a return on equity of 23.61%. Waters Corporation’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period last year, the company posted $1.57 EPS. research analysts predict that Waters Corporation will post 7.42 earnings per share for the current fiscal year.

WARNING: This article was published by Watch List News and is the property of of Watch List News. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States & international copyright legislation. The original version of this article can be read at https://www.watchlistnews.com/waters-corporation-wat-director-sells-700105-00-in-stock/1723361.html.

WAT has been the topic of several recent research reports. Jefferies Group LLC reaffirmed a “hold” rating and issued a $175.00 target price on shares of Waters Corporation in a research note on Thursday, August 31st. Cowen Inc reaffirmed a “hold” rating and issued a $190.00 target price on shares of Waters Corporation in a research note on Friday, November 3rd. BidaskClub lowered shares of Waters Corporation from a “strong-buy” rating to a “buy” rating in a research note on Friday, July 28th. Zacks Investment Research lowered shares of Waters Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 27th. Finally, Deutsche Bank AG raised their target price on shares of Waters Corporation from $199.00 to $200.00 and gave the company a “hold” rating in a research note on Wednesday, October 25th. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $193.62.

Hedge funds have recently made changes to their positions in the business. Dimensional Fund Advisors LP raised its holdings in Waters Corporation by 0.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 209,081 shares of the medical instruments supplier’s stock worth $38,436,000 after buying an additional 1,448 shares during the period. Assenagon Asset Management S.A. acquired a new stake in Waters Corporation during the 3rd quarter worth approximately $3,446,000. Advisory Services Network LLC raised its holdings in Waters Corporation by 6.0% during the 2nd quarter. Advisory Services Network LLC now owns 1,145 shares of the medical instruments supplier’s stock worth $210,000 after buying an additional 65 shares during the period. UBS Asset Management Americas Inc. raised its holdings in Waters Corporation by 46.7% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 374,472 shares of the medical instruments supplier’s stock worth $68,843,000 after buying an additional 119,130 shares during the period. Finally, Chicago Equity Partners LLC acquired a new stake in Waters Corporation during the 2nd quarter worth approximately $3,230,000. Hedge funds and other institutional investors own 92.04% of the company’s stock.

Waters Corporation Company Profile

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Insider Buying and Selling by Quarter for Waters Corporation (NYSE:WAT)

Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.